# This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 34% on Good News.

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-10 19:29 UTC · Category: Business · Sources: 7 · Current Velocity: 5.29

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| TradingView | Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today? | 2026-08-10 16:20 | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxPUGlkNzhEYkE4MGZfTXgtanc4LTAxQzhDRENVYTNIS1JOd2NyUEdnRVQzblBvcF8zLVZOQmphU0c1Z2RNbDFYSlU2amhoZVFZTkZqUzN6VXJVVlE1S3Y1VjktVTVhYnVQbUR2Vjd3R3M4Z0UzT1UxODlaMHc3OXV5U2hrQ0xicmlKdFUtRm9rMGVhV3l6QnFkR1BkZE4tMm9Qbm13MXVqLWxYcWxqZFg5OWdSREU?oc=5) |
| The Globe and Mail | AbCellera stock soars on ‘off the chart’ trial results from hot flash treatment for menopausal women | 2026-08-10 16:20 | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxOdndfVzR4R3h6Qy0yVklSZ0JmeUM5OURiTVlQaGxNejN2SWdSaExrdWFGN0g0cGRnWEgxWXoySGYxZzdhMzg4a1Q1ZnQxSnloclBwcEMwV0pMVkVlYzVOeUtrQmw5ZElzMmpIRW5paG5YRDhlZVBjQlZNekNVMkxZRWZpLWVWczhkeTRNT2RrOXVxVlBZR1lMOW44VmpJWnBoTzhtOTJ0TTNoeVlM?oc=5) |
| Yahoo Finance | AbCellera Stock Jumps 33% on a Positive Menopause Trial | 2026-08-10 16:20 | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxNd09NMWNycmZjX0doWWk5ZmpmOGlubGE0cGd4N2pFdVBJNDdMZGhuWWg4U3pDZjk0WHhVODBCak9FVTBkQS12NHBpTHkxeHZfOHNiOGl0QzJtMDFoWV9yLUttU2JwMlpaX2N6UUJ0SEg3YU9zT0ZkNkNqa0R4RnVrM2Utc2VUSWlsakZvaTBsVDFia1JaRHc3RF9B?oc=5) |
| Bloomberg.com | Hot-Flash Drug Trial Result Sends AbCellera Up as Much as 41% | 2026-08-10 16:20 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxNRGZOUXo2Z1NkMEtNa1RUQlhzOG84MzZmNUh6V2tzWWh6RVVSeEE1QXp0ajVVa0w1RGlVd3h0eFQ2bG5WdWNjNXNRVmdFZFN5THhuS0lvX3Ywak93QlNQRHVrSXJBMV93RmJBcjZzakhGRF9KZV9MaXJSX2t1MWxreWlKazF0WkJuVjBvaS16ZDNvXzJvbHJwUjNjWmdDYWZLWnYzZTU1bkZfTmRac1FMSHpCOUpPdw?oc=5) |
| Fierce Biotech | AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice | 2026-08-10 16:20 | [Source Link](https://news.google.com/rss/articles/CBMivwFBVV95cUxNRkJtZkRBVktNWkZOdXZhTzhWWE5RSGtrLVJ6QTRBUEk4REJfTHU1T1dJS0tOSE9jRHRPZG5xYnNYWG02aFM3Q2w3VThzcUwtM3QyNEhaby1nMkpXTkMyT2RERElRX0ZwNUJoRkxLN3BTN2JUcGNyWUo3Tm02MFNXNE42V2V4eFlfZHFuZmRldURkWUlMVWFoS1BOelRtM21RbjJEaXBBRWJRWERXdXdTLUZfWkE4NWZOLTZSNnhJWQ?oc=5) |
| Business Wire | AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile | 2026-08-10 16:20 | [Source Link](https://news.google.com/rss/articles/CBMi9AJBVV95cUxNalBUQnd2bWs5ZlZvUVZwQ3hIV1U3SHZHZWYzNFhBWnVwUGZTU3lDQUJqbzRfOTc4ck9BZ091WjEtSHBRQ1pZYUNQTWE5eFB5MV9sc3ZLQUE2NGN0WHRaZUZpNlVMMzhBX2llOEY3VWdzWVBtbFBEZ0oyd24tR1RxUndtSDB0LWJjZE84d1RwUVRGeXFPM25tTHpOM2pZUzNGYlRtNjNid1c4a0FRb0xVQWhCMnFsQVRvOHY5U0ZuTGEyWXlkQVNVZ0NaQUd1N1RIWTRuSmxmRmdxdm84a0NhVWFvalJURFFGVXoxZlhzYm56V1dRMGJ2QktrWFRocm5BSzQ5MHh2aGYxcmFUTldZSnRlSjlubnFWNk9xSXdLT2xPTzZVdlZVTkJRZElvY29KLTVrQlFRN2ZZX3ZWLVhsTlBhRWdqYzFMQ0F3Q2wtOWIyWDByQkx) |
| Yahoo Finance | AbCellera’s ABCL-635 Cuts Menopause Hot Flashes 83% in Phase II Trial | 2026-08-10 16:20 | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxPQURrSUsybkktTXZ3a0tCMmdnbFFmcy16NDVvWC1rVy1kbkZNcmhqQ2ZRVHlwS3Y3WDZOMXRQQmQ4dkNSbU9UZ3o5M0h2RFFyMzdWbDd3LVJBREZuOVhVN1VRSG1nWHltNmZHX256VG92LWZ3RUtTTUdsWnJtdTBia1dERkFPS3hTTXZzTllLOHBTSERrNVkyTWRn?oc=5) |
| Barron's | This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 34% on Good News. | 2026-08-10 16:20 | [Source Link](https://news.google.com/rss/articles/CBMifEFVX3lxTE9JdV81NTVXX1dyb01BQjNiZHFtMmZFM3RXWDJySVUxcFZlMEhzTDZreVFUVFZTRWoyR3NtbGc2Mm52Vm1sR0ZfdnVrRHQ3MXJ0UTdHSzhJek9YTzlSaWJFNklhOEVIdzlzTzhNeFFrOUJ0SlIwT2cwZmVvQWg?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-10/this-biotech-s-drug-could-treat-hot-flashes-the-stock-is-up-34-on-good-news*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*